← back to search

Julia Cadrin‐Tourigny

Montreal Heart Institute · CA
Area of research
Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiovascular Effects of Exercise, Cardiac electrophysiology and arrhythmias, Cardiomyopathy and Myosin Studies, and Cardiac Arrhythmias and Treatments.
h-index
30
citations
3,509
works
145
NIH funding
primary concept
Medicine
email

Recent publications

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy
Nature Genetics 2025cited by 51position: middledoi
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants
Circulation 2025cited by 21position: middledoi
Natural History and Clinical Outcomes of Patients With <i>DSG2/DSC2</i> Variant-Related Arrhythmogenic Right Ventricular Cardiomyopathy
Circulation 2025cited by 19position: middledoi
Clinical features and outcomes in carriers of pathogenic desmoplakin variants
European Heart Journal 2024cited by 61position: middledoi
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers
European Heart Journal 2024cited by 55position: middledoi
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
JACC Advances 2024cited by 40position: middledoi
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
European Heart Journal 2024cited by 19position: lastdoi
Catheter Ablation for Ventricular Tachycardia in Patients With Desmoplakin Cardiomyopathy
JACC. Clinical electrophysiology 2024cited by 16position: middledoi
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
EP Europace 2023cited by 17position: middledoi
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy
New England Journal of Medicine 2022cited by 351position: middledoi
A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
European Heart Journal 2022cited by 127position: firstdoi
Acute Myocarditis Associated With Desmosomal Gene Variants
JACC Heart Failure 2022cited by 125position: middledoi
Arrhythmogenic Right Ventricular Cardiomyopathy
JACC. Clinical electrophysiology 2022cited by 123position: middledoi
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator
European Heart Journal 2022cited by 72position: lastdoi
Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
Circulation 2022cited by 41position: lastdoi
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
Nature Genetics 2021cited by 290position: middledoi
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
Circulation Genomic and Precision Medicine 2021cited by 231position: middledoi
Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy
Circulation Arrhythmia and Electrophysiology 2020cited by 114position: firstdoi
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of <i>CASQ2</i> -Catecholaminergic Polymorphic Ventricular Tachycardia
Circulation 2020cited by 83position: middledoi
Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation
EP Europace 2020cited by 71position: middledoi
Retracted and Republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
European Heart Journal 2019cited by 253position: firstdoi
Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis
Heart Rhythm 2018cited by 110position: middledoi
Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
Journal of the American Heart Association 2018cited by 30position: middledoi
Systolic Blood Pressure and Mortality in Patients with Atrial Fibrillation and Heart Failure: Insights from the AFFIRM and AF-CHF Studies
European Journal of Heart Failure 2014cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Cynthia A. James · University of Groningen6 papers (2018–2024)Hugh Calkins · The University of Texas Southwestern Medical Center6 papers (2018–2024)J. Peter van Tintelen · University Medical Center Utrecht4 papers (2018–2023)Brittney Murray · Tripler Army Medical Center4 papers (2018–2024)Anneline S.J.M. te Riele · Utrecht University3 papers (2018–2023)Crystal Tichnell · Twitter (United States)3 papers (2018–2024)Harikrishna Tandri · University of Groningen3 papers (2018–2024)Jason G. Andrade · Vancouver Biotech (Canada)2 papers (2014–2022)Richard Carrick · University of Vermont2 papers (2023–2024)Laurens P. Bosman · Netherlands Heart Institute2 papers (2018–2020)Alessio Gasperetti · Utrecht University2 papers (2023–2024) · 2 papers (2023–2024)Alexandros Protonotarios · St Bartholomew's Hospital2 papers (2021–2023)Folkert W. Asselbergs · The University of Texas Southwestern Medical Center2 papers (2018–2020)Laurent Macle · Université du Québec à Montréal2 papers (2014–2022)Paul Khairy · Health Innovations (United States)2 papers (2014–2020)Richard N.W. Hauer · University of Wisconsin–Stevens Point2 papers (2018–2020)Stefan L. Zimmerman · University Radiology1 papers (2020–2020) · 1 papers (2022–2022)Jeroen F. van der Heijden · Haga Hospital1 papers (2020–2020)